Bold pursuits require persistence and curiosity
I hope this message finds you and your family safe, healthy and having had the opportunity to enjoy the holiday season. Safe and healthy is no small hurdle to surpass as of late. Over the past few months, we have encountered tornadoes, fires, storms and a new COVID variant that is making its way through…
Former HFMA National Board member Goldstein joins Kaufman Hall
Lisa Goldstein, MPA, a leading expert in not-for-profit healthcare, has joined Kaufman, Hall & Associates, LLC, as a senior vice president. Goldstein previously was an associate managing director for Moody’s Investors Service, where she managed the agency’s U.S. not-for-profit healthcare ratings team and oversaw the accuracy, consistency and monitoring of its not-for-profit hospital ratings. Goldstein…
David Johnson: Cracks in the foundation — 5 structural defects are undermining nonprofit healthcare
The relentless organizational imperative under which nonprofit healthcare providers operate to optimize revenues under fee-for-service medicine has led to fragmented care delivery, unsustainable cost growth and severed connections with American consumers. Nonprofits should address five structural defects to their modus operandi that stand in the way of their delivering care empathetically and cost effectively to their patients.
Shawn Stack: No Surprises Act is important move toward meaningful consumer transparency
The No Surprises Act, which became effective on Jan. 1 of 2022, will clearly benefit patients, .ut its larger impact is yet to be seen as the industry awaits the release of provisions targeting health plans and payers.
U.S. healthcare system is poised to begin a new phase in partnerships
Healthcare provider organizations should prepare for an emerging new phase in the evolution of healthcare partnerships, characterized by an increasingly diverse array of choices among care sites and settings for consumers, health plans and employers. In responding to the opportunities presented in this new partnership phase, providers should adopt a strategy that applies important lessons learned during the pandemic.
Accelerated drug approvals present a mounting challenge to oncologists and raises concerns about cost effectiveness for health system finance leaders
In the past year, Americans have witnessed two extremes of the FDA’s accelerated approval process, exposing both profound strengths and worrisome weaknesses. Finance leaders should keep informed about new drug treatment options, their associated costs and efficacy and whether lower-cost alternatives that have the same efficacy are available so they can engage in meaningful conversations with clinicians about which options truly promote cost effectiveness of health.
How to create an employer-friendly healthcare center of excellence
Increasing health expenditures and the pressures of the recent pandemic have contributed to the development of a new type of center of excellence (COE), called the future-state COE, which is designed to better address the needs of large employers. This COE model incorporates value-based contracting and a strong incentive design into a service-line strategy to create employee health programs that benefit employers, patients and providers alike.
Relief meets reality: The pandemic is not over yet
HFMA President and CEO Joe Fifer reflects on another challenging year for healthcare.
Jill Geisler: 9 ways difficult conversations go south and how to keep that from happening
Avoiding difficult conversations can lead to unhealthy organizations. Jill Geisler talks about common ways conversations can derail and how leaders can get them back on track.
6 things leaders can do to foster civility in the workplace
Times are turbulent, and people often feel empowered to express their opinions, even in negative ways. Jill Geisler shares things leaders can do to promote civility in the workplace and keep teams working well together.